Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Recruiting · NCT05806580 · Registry updated 2024-10-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 4 | 2024-10-23 | NCT05806580 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NO.197， Ruijin Er Road | Shanghai | China | 1 |